Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AMTRIX-D for Hand Tendon Adhesions
NCT06723782Phase 2Completed
- Sponsor
- TBF Génie Tissulaire
- Start
- Feb 2024
- Primary completion
- Sep 2026
- Modality
- Biologic
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of AMTRIX-D in Tendon adhesion, sponsored by TBF Génie Tissulaire. Primary endpoint: Change in the finger total active range of motion at 6 months. Started Feb 2024; status: completed.
02
Drugs
AMTRIX-D
03
Conditions
Tendon adhesion
Beyond the preview
Go deeper on NCT06723782.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06723782.